Plan A Wealth LLC Has $511,000 Holdings in VanEck Biotech ETF $BBH

Plan A Wealth LLC trimmed its holdings in shares of VanEck Biotech ETF (NASDAQ:BBH) by 56.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,087 shares of the company’s stock after selling 3,962 shares during the period. Plan A Wealth LLC owned 0.16% of VanEck Biotech ETF worth $511,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Jane Street Group LLC bought a new stake in shares of VanEck Biotech ETF during the first quarter worth $659,000. Bleakley Financial Group LLC bought a new stake in VanEck Biotech ETF during the 2nd quarter worth about $2,909,000. Flagship Harbor Advisors LLC increased its position in VanEck Biotech ETF by 12.9% in the 2nd quarter. Flagship Harbor Advisors LLC now owns 2,460 shares of the company’s stock valued at $377,000 after acquiring an additional 281 shares in the last quarter. Rockefeller Capital Management L.P. raised its stake in shares of VanEck Biotech ETF by 2.6% in the second quarter. Rockefeller Capital Management L.P. now owns 11,811 shares of the company’s stock worth $1,811,000 after acquiring an additional 294 shares during the last quarter. Finally, Raymond James Financial Inc. lifted its position in shares of VanEck Biotech ETF by 245.9% during the second quarter. Raymond James Financial Inc. now owns 67,940 shares of the company’s stock worth $10,414,000 after purchasing an additional 48,297 shares in the last quarter. Institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Price Performance

BBH opened at $195.86 on Wednesday. The company’s 50 day simple moving average is $193.64 and its 200-day simple moving average is $180.51. VanEck Biotech ETF has a one year low of $135.34 and a one year high of $202.91.

VanEck Biotech ETF Dividend Announcement

The company also recently disclosed an annual dividend, which was paid on Friday, December 26th. Shareholders of record on Monday, December 22nd were given a $0.9565 dividend. This represents a yield of 50.0%. The ex-dividend date was Monday, December 22nd.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.